DrDaniel Alencar Rodrigues
Lecturer
School of Pharmacy and Biomolecular Sciences
Orcid identifier0000-0001-7898-7093 (opens in a new tab)
- LecturerSchool of Pharmacy and Biomolecular Sciences
- Royal College of Surgeons in Ireland, School of Pharmacy and Biomolecular Sciences, 1st Floor Ardilaun House Block B, 111 St Stephen's Green, Dublin 2, Dublin, Ireland
BIOGRAPHY
Dr. Rodrigues is a highly skilled researcher and lecturer with over 10 years of experience in organic synthesis and medicinal chemistry, dedicated to the development of novel therapeutic strategies against cancer. He completed his Ph.D. at the Federal University of Rio de Janeiro, Brazil, where his research focused on designing multi-target compounds as inhibitors of histone deacetylase 6 (HDAC6) and phosphatidylinositol-3-kinase (PI3K). This work involved comprehensive studies on structure-activity relationships (SAR) and the use of in silico techniques such as molecular docking, leading to significant advancements in the field.
Currently, Dr. Rodrigues is a lecturer at the Royal College of Surgeons in Ireland, Dr. Rodrigues leads innovative research projects that explore the design, synthesis, and evaluation of novel multi-target drugs and Proteolysis Targeting Chimeras (PROTACs). His post-doctoral work under Prof. Tríona Ní Chonghaile supervision focused on the role of HDAC6 in triple-negative breast cancer, contributing to the development of lead compounds based on an atypical HDAC6 inhibitor with improved pharmacological properties. This research has resulted in a patent and garnered recognition through prestigious awards, including the Government of Ireland Postdoctoral Fellowship.
With a robust publication record and a passion for mentoring the next generation of scientists, Dr. Rodrigues aims to be at the forefront of medicinal chemistry research. His career is driven by a personal commitment to leverage his expertise in medicinal chemistry to contribute to the fight against cancer.
As an accomplished researcher in the fields of organic synthesis and medicinal chemistry, Dr. Rodrigues lab is driven for innovation and commitment to developing novel therapeutic agents. His lab has a multidisciplinary approach, which explores:
1) Cutting-Edge Research: Design and synthesis of multi-target drugs and Proteolysis Targeting Chimeras (PROTACs) aimed at selective degradation of cancer targets.
2) Advanced Synthesis Techniques: Small-scale organic reactions, purification, and characterisation of complex molecules using state-of-the-art spectroscopic methods.
3) Computational Chemistry: In silico modeling and molecular docking to inform compound design and optimise pharmacological properties.
Currently, Dr. Rodrigues is a lecturer at the Royal College of Surgeons in Ireland, Dr. Rodrigues leads innovative research projects that explore the design, synthesis, and evaluation of novel multi-target drugs and Proteolysis Targeting Chimeras (PROTACs). His post-doctoral work under Prof. Tríona Ní Chonghaile supervision focused on the role of HDAC6 in triple-negative breast cancer, contributing to the development of lead compounds based on an atypical HDAC6 inhibitor with improved pharmacological properties. This research has resulted in a patent and garnered recognition through prestigious awards, including the Government of Ireland Postdoctoral Fellowship.
With a robust publication record and a passion for mentoring the next generation of scientists, Dr. Rodrigues aims to be at the forefront of medicinal chemistry research. His career is driven by a personal commitment to leverage his expertise in medicinal chemistry to contribute to the fight against cancer.
As an accomplished researcher in the fields of organic synthesis and medicinal chemistry, Dr. Rodrigues lab is driven for innovation and commitment to developing novel therapeutic agents. His lab has a multidisciplinary approach, which explores:
1) Cutting-Edge Research: Design and synthesis of multi-target drugs and Proteolysis Targeting Chimeras (PROTACs) aimed at selective degradation of cancer targets.
2) Advanced Synthesis Techniques: Small-scale organic reactions, purification, and characterisation of complex molecules using state-of-the-art spectroscopic methods.
3) Computational Chemistry: In silico modeling and molecular docking to inform compound design and optimise pharmacological properties.
ACADEMIC POSITIONS
- LecturerRoyal College of Surgeons in Ireland, School of Pharmacy and Biomolecular Sciences, Dublin, Ireland7 Aug 2023
- Postdoctoral researcherRoyal College of Surgeons in Ireland, Department of Physiology and Medical Physics, Dublin, Ireland19 Oct 2020 - 31 Jul 2023
- Assistant ProfessorFederal University of Rio de Janeiro, Department of Chemistry, Rio de Janeiro, Brazil1 Mar 2017 - 31 Dec 2018
DEGREES
- Postgraduate Diploma (PG Dip) in Health Professions EducationRoyal College of Surgeons in Ireland, Dublin, Ireland5 Sep 2023 - 31 Aug 2024
- Ph.D in ChemistryFederal University of Rio de Janeiro, Rio de Janeiro, Brazil1 Aug 2015 - 9 Aug 2019
- M.Sc. in ChemistryFederal University of Rio de Janeiro, Rio de Janeiro, Brazil4 Mar 2013 - 15 Apr 2015
- Bachelor in PharmacyFederal University of Goias, Goiania, Brazil3 Mar 2008 - 21 Dec 2012
LANGUAGES
- Portuguese
- English
RESEARCH SUB-AREAS
- Medicinal Chemistry
- Chemical Biology
- Breast Cancer
- Brain Cancer
- Synthetic Chemistry
SUSTAINABLE DEVELOPMENT GOALS (UNSDGS)
- 4 Quality Education
- 3 Good Health and Well Being
- 9 Industry, Innovation and Infrastructure